N/A
N=592
Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.
Diabetes Mellitus
Bottom Line
View on ClinicalTrials.gov: NCT05435157 ↗Enrolled (actual)
592
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Residual Gastric Volume — 22.1; 33.1; 40.2 mL — p=<0.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
- Primary completion
- Dec 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Residual Gastric Volume |
22.1; 33.1; 40.2 | <0.05 sig |
| SECONDARY Antral Cross-Sectional Area |
5.7; 5.4; 7.1 | <0.05 sig |
Summary
Comparison of residual gastric volume measure by ultrasounds between diabetic and non-diabetic patients scheduled for elective surgery
Eligibility Criteria
Inclusion Criteria
- BMI<40 kg.m-2;
- Age over 18 years;
- American Society of Anesthesiologists' physical status status I-III
- who were to undergo elective surgery and had the ability to understand the rationale of the study and provide informed consent
Exclusion Criteria
- Pregnancy
- Recent upper gastrointestinal bleed (< 1 month)
- Abnormal anatomy of the upper gastrointestinal tract (such as hiatal hernias and gastric tumors)
- Previous surgical procedures on the esophagus, stomach, or upper abdomen
- Gastroesophageal reflux disease
- Previous use of prokinetics or high doses of opiates.
Data sourced from ClinicalTrials.gov (NCT05435157). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.